Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,262,529
-$4,643,252 QoQ
Shares Held
5,805
-77.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $1,197,745,873 across 8 Drug Manufacturers - General names. ABBV ranks #5 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,026,556 | $944,195,412 | |
| 2 | BIIB |
Biogen Inc.
|
1,160,989 | $212,844,113 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
230,625 | $32,142,206 | |
| 4 | JNJ |
Johnson & Johnson
|
16,925 | $4,137,147 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
5,805 | $1,262,529 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,177 | $1,163,085 | |
| 7 | PFE |
Pfizer Inc
|
35,847 | $1,006,583 | |
| 8 | MRK |
Merck & Co., Inc.
|
8,270 | $994,798 |
All Filings in ABBV
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,262,529 | 5,805 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,905,781 | 25,847 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $4,336,975 | 18,731 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $217,473,505 | 1,171,606 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $242,885,850 | 1,159,249 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,066,200 | 6,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $921,679,643 | 4,667,205 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $827,706,293 | 4,825,713 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $880,796,212 | 4,836,882 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $750,384,576 | 4,842,128 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $931,804,617 | 6,251,205 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $808,051,393 | 5,997,561 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,210,814,053 | 7,597,503 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $530,069,810 | 3,279,932 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||